Targeted removal of macrophage-secreted interleukin-1 receptor antagonist protects against lethal Candida albicans sepsis

被引:13
|
作者
Gander-Bui, Hang Thi Thuy [1 ,2 ]
Schlaurofli, Joeurolle [1 ]
Baumgartner, Johanna [1 ,2 ]
Walthert, Sabrina [1 ]
Genitsch, Vera [3 ]
van Geest, Geert [4 ]
Galvan, Jose A. [3 ]
Cardozo, Carmen [3 ]
Martinez, Cristina Graham [3 ]
Grans, Mona [5 ]
Muth, Sabine [5 ]
Bruggmann, Remy [4 ]
Probst, Hans Christian [5 ]
Gabay, Cem [6 ]
Freigang, Stefan [1 ]
机构
[1] Univ Bern, Inst Tissue Med & Pathol, Div Expt Pathol, CH-3008 Bern, Switzerland
[2] Univ Bern, Grad Sch Cellular & Biomed Sci, CH-3012 Bern, Switzerland
[3] Univ Bern, Inst Tissue Med & Pathol, CH-3008 Bern, Switzerland
[4] Univ Bern, Interfac Bioinformat Unit, CH-3012 Bern, Switzerland
[5] Univ Med Ctr Mainz, Inst Immunol, D-55131 Mainz, Germany
[6] Univ Hosp Geneva, Dept Med, Div Rheumatol, CH-1211 Geneva, Switzerland
基金
瑞士国家科学基金会;
关键词
HOST-DEFENSE; NLRP3; INFLAMMASOME; DENDRITIC CELLS; IMMUNITY; INNATE; RECOGNITION; INTERFERONS; HOMEOSTASIS; INFECTIONS; DEFICIENCY;
D O I
10.1016/j.immuni.2023.06.023
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Invasive fungal infections are associated with high mortality rates, and the lack of efficient treatment options emphasizes an urgency to identify underlying disease mechanisms. We report that disseminated Candida albicans infection is facilitated by interleukin-1 receptor antagonist (IL-1Ra) secreted from macrophages in two temporally and spatially distinct waves. Splenic CD169+ macrophages release IL-1Ra into the bloodstream, impeding early neutrophil recruitment. IL-1Ra secreted by monocyte-derived tissue macrophages further impairs pathogen containment. Therapeutic IL-1Ra neutralization restored the functional competence of neutrophils, corrected maladapted hyper-inflammation, and eradicated the otherwise lethal infection. Conversely, augmentation of macrophage-secreted IL-1Ra by type I interferon severely aggravated disease mortality. Our study uncovers how a fundamental immunoregulatory mechanism mediates the high disease susceptibility to invasive candidiasis. Furthermore, interferon-stimulated IL-1Ra secretion may exacerbate fungal dissemination in human patients with secondary candidemia. Macrophage-secreted IL-1Ra should be considered as an additional biomarker and potential therapeutic target in severe systemic candidiasis.
引用
收藏
页码:1743 / +
页数:28
相关论文
共 50 条
  • [41] Increased expression of mRNA encoding interleukin-1β and caspase-1, and the secreted isoform of interleukin-1 receptor antagonist in the rat brain following systemic kainic acid administration
    Eriksson, C
    Tehranian, R
    Iverfeldt, K
    Winblad, B
    Schultzberg, M
    JOURNAL OF NEUROSCIENCE RESEARCH, 2000, 60 (02) : 266 - 279
  • [42] Interleukin-10 and interleukin-1 receptor antagonist distinguish between patients with sepsis and the systemic inflammatory response syndrome (SIRS)
    Potjo, Moliehi
    Theron, Annette J.
    Cockeran, Riana
    Sipholi, Ndisha N.
    Steel, Helen C.
    Bale, Tsohadi V.
    Meyer, Pieter W. A.
    Anderson, Ronald
    Tintinger, Gregory R.
    CYTOKINE, 2019, 120 : 227 - 233
  • [43] Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation
    Küster, H
    Weiss, M
    Willeitner, AE
    Detlefsen, S
    Jeremias, I
    Zbojan, J
    Geiger, R
    Lipowsky, G
    Simbruner, G
    LANCET, 1998, 352 (9136): : 1271 - 1277
  • [44] INTERLEUKIN-1 RECEPTOR ANTIBODY (IL-1RAB) PROTECTION AND TREATMENT AGAINST LETHAL ENDOTOXEMIA IN MICE
    MCNAMARA, MJ
    NORTON, JA
    NAUTA, RJ
    ALEXANDER, HR
    JOURNAL OF SURGICAL RESEARCH, 1993, 54 (04) : 316 - 321
  • [45] COST-EFFECTIVENESS OF TREATMENT WITH INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1RA) IN PATIENTS WITH SEPSIS SYNDROME
    GORDON, GS
    FISHER, CJ
    SLOTMAN, GJ
    OPAL, SM
    PRIBBLE, JP
    STILES, DM
    CATALANO, MA
    CLINICAL RESEARCH, 1992, 40 (02): : A254 - A254
  • [46] PLASMA-CLEARANCE (CL) OF INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1RA) IN PATIENTS WITH SEPSIS SYNDROME
    BLOEDOW, DC
    PRIBBLE, JP
    CATALANO, MA
    FISHER, CJ
    SCHENTAG, JJ
    JARESKO, GS
    BARRIERE, SL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 196 - 196
  • [47] Neurokinin-1 receptor antagonist treatment protects mice against lung injury in polymicrobial sepsis
    Hegde, Akhil
    Zhang, Huili
    Moochhala, Shabbir M.
    Bhatia, Madhav
    JOURNAL OF LEUKOCYTE BIOLOGY, 2007, 82 (03) : 678 - 685
  • [48] A bacteria-expressed mouse interleukin-1 receptor antagonist peptide protects alginate-poly-L-lysine-alginate microencapsulated rat islets against the suppressive effect of interleukin-1 beta in vitro
    Hsu, BRS
    Chang, FH
    Fu, SH
    Huang, YY
    Juang, JH
    Huang, HS
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (03) : 1961 - 1963
  • [49] An anti-inflammatory property of Candida albicans β-glucan: Induction of high levels of interleukin-1 receptor antagonist via a Dectin-1/CR3 independent mechanism
    Smeekens, Sanne P.
    Gresnigt, Mark S.
    Becker, Katharina L.
    Cheng, Shih-Chin
    Netea, Stejara A.
    Jacobs, Liesbeth
    Jansen, Trees
    van de Veerdonk, Frank L.
    Williams, David L.
    Joosten, Leo A. B.
    Dinarello, Charles A.
    Netea, Mihai G.
    CYTOKINE, 2015, 71 (02) : 215 - 222
  • [50] STABLE EXPRESSION OF AN INSULIN INTERLEUKIN-1 RECEPTOR ANTAGONIST HYBRID GENE IN AN INSULIN-PRODUCING CELL-LINE CONFERS RESISTANCE AGAINST INTERLEUKIN-1
    WELSH, N
    GOKTURK, C
    BENDTZEN, K
    WELSH, M
    DIABETOLOGIA, 1993, 36 : A83 - A83